Profil bibliographique

Yagnapriya Ammakola

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

2Publications signalées
0Citations signalées
0Affiliations récentes

Les domaines associés

Pancreatic and Hepatic Oncology ResearchGastric Cancer Management and OutcomesNeuroendocrine Tumor Research AdvancesHER2/EGFR in Cancer ResearchColorectal Cancer Treatments and Studies

Les publications récentes

Accès ouvert 2026 conference-abstract OpenAlex

Efficacy and safety of trastuzumab deruxtecan in HER2-positive advanced gastric and gastroesophageal junction cancers: A meta-analysis of real-world studies and clinical trials.

Nitya Batra, Mahnoor Sukaina, Yagnapriya Ammakola, Rahul Mishra et autres

402 Background: Trastuzumab deruxtecan (T-DXd) is a HER2-targeted antibody-drug conjugate (ADC) with a cytotoxic payload. TDXd was approved in 2021 to be used in advanced gastric or GEJ cancers. Although given the recent approval, real-world evidence on efficacy and safety is limited. …

us, pk (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2026 conference-abstract OpenAlex

Race and income-related disparities in survival outcomes in patients with pancreatic neuroendocrine tumors: A SEER-based analysis.

Yagnapriya Ammakola, Aagamjit Singh, Chandra Kakarala, Mahnoor Sukaina et autres

672 Background: Racial and income-related disparities in gastrointestinal (GI) cancers influence access to care and survival outcomes. While pancreatic neuroendocrine tumors (PNETs) are rare, differences in treatment and prognosis across groups remain understudied, especially for islet cell-type benign PNETs which are excluded …

us, pk (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.